Stay updated on KN035: Pembrolizumab in Advanced Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the KN035: Pembrolizumab in Advanced Solid Tumors Clinical Trial page.

Latest updates to the KN035: Pembrolizumab in Advanced Solid Tumors Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe site footer now identifies the platform as revision v3.8.0 instead of v3.7.2.SummaryDifference0.1%

- Check20 days agoChange DetectedThe study record’s October 2026 update shows that recruitment has closed and the study is no longer looking for participants. The latest version also includes changes to the study status, design, and outcome measures.SummaryDifference2%

- Check27 days agoChange DetectedThe site footer revision changed from v3.7.1 to v3.7.2.SummaryDifference0.1%

- Check34 days agoChange DetectedThe site footer now identifies the website as revision v3.7.1 instead of v3.7.0.SummaryDifference0.1%

- Check48 days agoChange DetectedThe record history shows updates to the study's status and design, including changes to the arms/interventions and study description across versions, reflecting ongoing refinements to the trial details in the registry.SummaryDifference0.1%

- Check55 days agoChange DetectedFind contact information was added (lowercase 'c') and Find Contact Information was removed; the revision label changed from v3.6.6 to v3.7.0, reflecting a newer version in the history entries.SummaryDifference0.2%

Stay in the know with updates to KN035: Pembrolizumab in Advanced Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the KN035: Pembrolizumab in Advanced Solid Tumors Clinical Trial page.